Quinoline Derivatives in Medicinal Chemistry

Quinoline and its structurally related derivatives represent a privileged scaffold in drug discovery, owing to the fusion of a benzene ring with a pyridine nucleus that imparts both aromatic stability and versatile substitution chemistry. Over the past decade, synthetic modifications of the quinoline core have delivered compounds with diverse biological activities, including antimalarial, antibacterial, anticancer and anti-inflammatory properties. Key strategies involve ring functionalisation (such as halogenation, formylation and alkylation), heterocycle fusion to yield benzoquinolines or azoloquinolines, and hybridisation with other pharmacophores to overcome drug resistance and enhance selectivity. Structure–activity relationship studies have elucidated the impact of substituent patterns on target engagement, while molecular docking and in vitro assays continue to guide optimisation of potency and pharmacokinetic profiles. Globally, quinoline derivatives contribute to frontline therapies against malaria, multidrug-resistant bacteria and various cancers, underscoring their enduring importance in medicinal chemistry and the need for ongoing innovation to address emerging therapeutic challenges.

Research from Nature Portfolio

Recent studies have explored arylated benzo[h]quinoline derivatives as novel anticancer agents. These compounds induce oxidative stress–mediated DNA damage and trigger apoptosis in diverse human tumour cell lines, including melanoma and breast carcinoma. Molecular docking analyses suggest that benzo[h]quinolines occupy the hydrophobic pocket of key enzymes such as cyclin-dependent kinase 2 and aromatase, offering a dual mechanism that combines direct enzyme inhibition with pro-oxidant activity. Although initial bioavailability and drug-likeness profiles are promising, further optimisation of solubility and metabolic stability is under way to translate these scaffolds into viable therapeutic leads.

Quinoline Derivatives in Medicinal Chemistry publication trend

The graph below shows the total number of articles in quinoline derivatives in medicinal chemistry across all publications each year (not limited to Nature Index journals).

Technical terms

Quinoline: Heterocyclic aromatic compound comprising a benzene ring fused to a pyridine ring, serving as a core in many pharmacologically active molecules.

Benzo[h]quinoline: A fused tricyclic system in which an additional benzene ring is annulated onto the quinoline scaffold, often explored for enhanced anticancer potency.

Vilsmeier–Haack reagent: Electrophilic formylating agent generated from N,N-dimethylformamide and phosphorus oxychloride, widely used to install aldehyde groups on aromatic heterocycles.

PASS (Prediction of Activity Spectra of Substances): Computational tool that predicts potential biological activities of chemical compounds based on structural attributes and known activity spectra.

References

1. Unravelling the synthetic and therapeutic aspects of five, six and fused heterocycles using Vilsmeier–Haack reagent. RSC Advances (2023).
2. Synthesis and PASS-assisted evaluation of new heterocyclic compounds containing hydroquinoline scaffolds. BMC Chemistry (2024).
3. New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage. Scientific Reports (2016).